300267 尔康制药
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资49,753-0.09%49,79671,740120,229138,968
投资性房地产74,076-1.07%74,87778,08381,28885,263
固定资产2,024,648-1.33%2,052,0352,384,9732,577,8322,681,709
在建工程203,475-4.15%212,281174,575220,89052,917
无形资产312,643-1.41%317,123363,556378,034406,136
商誉2,0030.00%2,0032,0032,00310,008
其他非流动资产373,7432.58%364,344407,723367,778389,666
3,040,341-1.05%3,072,4593,482,6533,748,0553,764,668

流动资产
货币资金976,8358.85%897,405698,538744,350764,669
应收账款129,2176.80%120,992103,182109,154133,693
存货523,9302.33%511,995600,779691,603821,345
其他流动资产289,16712.01%258,173314,583185,907371,497
1,919,1497.30%1,788,5651,717,0821,731,0142,091,204

流动负债
短期借款684,50824.14%551,383488,198341,889396,641
应付票据0--0000
应付帐款113,472-6.28%121,072114,656122,299198,705
其他流动负债118,926-8.71%130,272102,487139,113130,087
916,90614.22%802,727705,342603,301725,433
流动资产净值1,002,2431.66%985,8381,011,7401,127,7131,365,771
资产总额减流动负债4,042,584-0.39%4,058,2974,494,3924,875,7685,130,439

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债83,267-1.16%84,24292,19965,75479,135
83,267-1.16%84,24292,19965,75479,135

总权益
    实收股本2,062,6050.00%2,062,6052,062,6052,062,6052,062,605
    储备项目1,959,573-0.61%1,971,6882,384,8212,773,4412,988,426
股东权益4,022,178-0.30%4,034,2934,447,4264,836,0465,051,031
非控股权益(62,862)4.36%(60,238)(45,232)(26,032)273